Clinical trial
Combination Chemotherapy With or Without Rituximab in Treating Patients With…
NCT00053092 · Institute of Cancer Research, United Kingdom, Other · Completed
Key facts
| NCT number | NCT00053092 |
|---|---|
| Title | Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma |
| Official title | National Mantle Cell Lymphoma Trial - Phase II Randomized Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma |
| Lead sponsor | Institute of Cancer Research, United Kingdom, Other |
| Collaborators | Australasian Leukaemia and Lymphoma Group |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug |
| Interventions | rituximab, cyclophosphamide, fludarabine phosphate |
| Enrollment | 82 |
| Start date | Oct 1, 2002 |
| Completion | Feb 1, 2009 |
| First posted | Jan 28, 2003 |
| Last update posted | Dec 18, 2013 |
| Countries | Australia, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: